Sensex climbs Mount 48,000 as investors cheer Covid-19 vaccine nod

The benchmark Sensex on Monday crossed the 48,000-mark for the first time as investors cheered the approval to two Covid vaccines by the Indian authorities. 

The drug regulator, on Sunday, had given its final nod to the vaccines developed by AstraZeneca with Oxford University and Bharat Biotech. The Sensex ended the session at 48,177, following a gain of 308 points or 0.64 per cent. The Nifty, on the other hand, rose 114 points, or 0.8 per cent, to end the session at 14,133. 

It took five sessions for the Sensex to reach the 48,000 level from 47,000. 

However, banking stocks fell and Reliance